KORU Medical Systems, Inc. (KRMD)
NASDAQHealth CareMedical - Instruments & SuppliesSnapshot 2026-09-04
$3.25+0.93%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - Instruments & SuppliesSnapshot 2026-09-04
QuarterlyIQ Insights · KRMD
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance recently climbed back into the top half of its industry — confirming the recovery.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -60.3% |
| Our one-year growth estimate | diamond | 18.2% |
Growth built into the price is above our model estimate.
The price assumes 78.5 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Model as of 2026-09-04 · Compared with 26 industry peers · Company calendar date is not available
KRMD — earnings in line
Dated 2026-05-06
RESULTS OF OPERATIONS AND FINANCIAL CONDITION. (a) Public Announcement or Release . On May 6, 2026, KORU Medical Systems, Inc. (the “Company”) issued a press release announcing its financial results for the first fiscal quarter ended March 31, 2026 and reiterating financial guidance for the fiscal year ended December 31, 2026. The Company’s press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. A related conference call will be held on May 6, 2026 at 4:30pm Eastern Tim…
Why it matters: New M&A activity could enhance KORU's market position and growth potential. It may attract investor interest.
Supportive ifAnnouncement of a new M&A deal or partnership.
Worry ifNo new M&A activity or negative news regarding previous deals.
Why it matters: Revenue growth guidance shows strong demand for KORU's products and good market position.
Supportive ifFull year 2026 revenue growth confirmed between $47.5 million and $48.5 million.
Worry ifGuidance revised down below $47.5 million for full year 2026.
Why it matters: Positive adjusted EBITDA shows KORU is making more money. This matters for investor trust.
Supportive ifAdjusted EBITDA is up in Q3.
Worry ifAdjusted EBITDA is down in Q3.
Why it matters: Faster growth in healthcare could help KORU Medical do better.
Supportive ifThe healthcare sector is showing revenue growth going back to 10% or more.
Worry ifHealthcare sector revenue growth keeps slowing down below current levels.
Why it matters: Progress in these trials could enhance KORU's market position and growth prospects.
Supportive ifThere is news of good Phase III trial results or important milestones.
Worry ifDelays or failures reported in the Phase III trials.
Why it matters: The earnings report will show if KORU Medical can improve its loss-making status.
Watch forEarnings report shows a reduction in losses compared to the previous quarter.
Also watch forEarnings report shows losses increasing or staying the same compared to the previous quarter.
Why it matters: This agreement could change KORU's supply chain and how much it can produce.
Watch forThey announced that the M&A agreement was successfully put into action.
Also watch forNews of delays or issues with the M&A agreement.
Why it matters: Falling below this growth rate could signal issues in KORU's market strategy or demand.
Worry ifQ3 revenue growth reported below 15% year over year.
Less concerning ifQ3 revenue growth reported at or above 15% year over year.
Why it matters: If it drops below this level, costs may rise. This could hurt profits.
Worry ifGross margin reported below 61% for Q3.
Less concerning ifGross margin reported at or above 61% for Q3.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
Usually moved in the same direction.
Price observations: 365 days
Most sensitive to the broad stock market.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$179 on $10,000 · ±1.8% | How much price usually moves either way. |
| Bad day | $440 loss on $10,000 · 4.4% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $5,092 loss on $10,000 · 50.9% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.